Hospital-initiated post-discharge medication reviews in Australia: expert opinion on the barriers and enablers to implementation

Manya Angley, Deirdre Criddle, Deborah Rigby, Rohan A. Elliott, Katie Phillips, Jonathan Penm, Janet K. Sluggett, Joy Gailer, Horst Thiele, Amy T. Page, Carly Pauw, Sarah Gillespie, Sepehr Shakib, Jerry Yik

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)


Medication-related harm can occur during transitions of care. Revised Home Medicines Review (HMR) and Residential Medication Management Review (RMMR) program rules were published in April 2020 which allowed provision for some hospital medical practitioners to refer at-risk patients for medication review. In turn, the Society of Hospital Pharmacists of Australia's (SHPA's) Transitions of Care and Primary Care Leadership Committee developed a framework to support hospitals facilitating Hospital-Initiated Medication Reviews (HIMRs) via three pathways: HMR, RMMR, and Hospital Outreach Medication Review. Following the compilation of draft barriers and enablers to implementation of the SHPA HIMR framework, refinement occurred after broad consultation with hospital- and primary care-based pharmacists with transitions of care experience. The finalised list of barriers and enablers can inform broadscale implementation of the SHPA HIMR framework to reduce medication-related harm when high-risk patients transition from hospital to primary care and aged care.

Original languageEnglish
Pages (from-to)446-453
Number of pages8
JournalJournal of Pharmacy Practice and Research
Issue number6
Publication statusPublished or Issued - Dec 2022


  • handover
  • hospital-initiated medication reviews
  • liaison pharmacy
  • medication safety
  • medication-related harm
  • post-discharge medication reviews
  • transitions of care

ASJC Scopus subject areas

  • Pharmacy
  • Pharmacology (medical)

Cite this